GABAB receptors and glucose homeostasis: evaluation in GABAB receptor knockout mice

1 Instituto de Biología y Medicina Experimental-Consejo Nacional de Investigaciones Científicas y Técnicas; 2 Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina; 3 Lawson Health Research Institute, St. Joseph's Health Care, London, Ontario, Canada; and 4 Department of Bi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of physiology: endocrinology and metabolism 2008-01, Vol.294 (1), p.E157-E167
Hauptverfasser: Bonaventura, M. M, Catalano, P. N, Chamson-Reig, A, Arany, E, Hill, D, Bettler, B, Saravia, F, Libertun, C, Lux-Lantos, V. A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:1 Instituto de Biología y Medicina Experimental-Consejo Nacional de Investigaciones Científicas y Técnicas; 2 Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina; 3 Lawson Health Research Institute, St. Joseph's Health Care, London, Ontario, Canada; and 4 Department of Biomedicine, University of Basel, Basel, Switzerland Submitted 16 November 2006 ; accepted in final form 22 October 2007 GABA has been proposed to inhibit insulin secretion through GABA B receptors (GABA B Rs) in pancreatic β-cells. We investigated whether GABA B Rs participated in the regulation of glucose homeostasis in vivo. The animals used in this study were adult male and female BALB/C mice, mice deficient in the GABA B1 subunit of the GABA B R (GABA B –/– ), and wild types (WT). Blood glucose was measured under fasting/fed conditions and in glucose tolerance tests (GTTs) with a Lifescan Glucose meter, and serum insulin was measured by ELISA. Pancreatic insulin content and islet insulin were released by RIA. Western blots for the GABA B1 subunit in islet membranes and immunohistochemistry for insulin and GABA B1 were performed in both genotypes. BALB/C mice preinjected with Baclofen (GABA B R agonist, 7.5 mg/kg ip) presented impaired GTTs and decreased insulin secretion compared with saline-preinjected controls. GABA B –/– mice showed fasting and fed glucose levels similar to WT. GABA B –/– mice showed improved GTTs at moderate glucose overloads (2 g/kg). Baclofen pretreatment did not modify GTTs in GABA B –/– mice, whereas it impaired normal glycemia reinstatement in WT. Baclofen inhibited glucose-stimulated insulin secretion in WT isolated islets but was without effect in GABA B –/– islets. In GABA B –/– males, pancreatic insulin content was increased, basal and glucose-stimulated insulin secretion were augmented, and impaired insulin tolerance test and increased homeostatic model assessment of insulin resistance index were determined. Immunohistochemistry for insulin demonstrated an increase of very large islets in GABA B –/– males. Results demonstrate that GABA B Rs are involved in the regulation of glucose homeostasis in vivo and that the constitutive absence of GABA B Rs induces alterations in pancreatic histology, physiology, and insulin resistance. -aminobutyric acid; insulin; glycemia; pancreas histology Address for reprint requests and other correspondence: V. A. Lux-Lantos, V. de Obligado 2490, (C1428ADN) Buenos Aires, Argentina (e-mail: vlux{at}dna.ub
ISSN:0193-1849
1522-1555
DOI:10.1152/ajpendo.00615.2006